Cytosorbents Corp

(CTSOD) Trade

By |

Profile

CytoSorbents Corp is a critical care immunotherapy company. It investigates and commercializes its blood purification technology to reduce uncontrolled inflammation in hospitalized patients internationally with the goal of preventing and treating multiple organ failure in life-threatening illnesses and cardiac surgery. Its product portfolio consists of Cytosord, Contrastsorb, Vetresq, Hemodefend and Drugsorb. The company's intellectual property consists of composition of matter, materials, methods of production, systems incorporating the technology and multiple medical uses. It derives its revenue from product sales and grants.

Contact Information

Website: www.cytosorbents.com
Email: avogel@cytosorbents.com
Main Phone: +1 732 329-8885
Address: 7 Deer Park Drive
Address 2: Suite K
State: NJ
City / Town: Monmouth Junction
Country: USA
Postal Code: 08852

Issuer Information

Exchange: NSC
CEO: Phillip P. Chan
Employees: 117
NAICS: Medical Laboratories(621511)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 31,651,821.00 EPS (TTM) -0.50 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 24 24 24 24
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 14.63 14.63 14.63 14.63
Standard Deviation 5.76 5.76 5.76 5.76
Date of Most Recent Estimate 06/02/16 06/02/16 06/02/16 06/02/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 3 4
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.2 1.2 1.25 1.2